Motley Fool Staff
February 20, 2014
Here are today's top news headlines from Fool.com. Check back throughout the day as this list is updated, and follow us on Twitter at TMFBreaking.
Stock Market Today: Wal-Mart Slips as Tesla Roars
Today's Biggest Biotech Stories: Antares Pharma Inc., BioCryst Pharmaceuticals Inc., and Raptor Pharmaceuticals Corp.
Facebook Buys WhatsApp for $19 Billion, But Overlooks 3 Big Problems
Invesco Mortgage Capital Sees $83 Million Loss in Fourth Quarter
Initial Jobless Claims Dip 0.9%
Manufacturing Index Rebounds to Fastest Growth in Nearly 4 Years
Marcellus Shale Natural Gas Production in Pa. Doubles Over Previous Year
Cold Weather Chills Philly Fed Manufacturing Report
Weak Housing Market Keeps Mortgage Rate Rises in Check
CPI: Electricity Index Posts Largest Gains Since March 2010
Japan Looks at Recycling Vehicle Batteries for Renewable Power
Why Avis Budget Group, Inc. Vroomed Today
Why Conn's Inc. Shares Got Crushed
Porsche Tells 911 GT3 Owners to Stop Driving the Vehicles
Why CryoLife, Inc. Shares Have Gone Ice-Cold
Peltz Prepares New Push for PepsiCo
Tesla Motors Inc. Stock Is Racing to New Heights: Is It Time to Sell or Buckle Up for the Long Haul?
Why Onconova Therapeutics Inc. Shares Imploded
Jobless Claims Report Pushes Stocks Higher
Obama Admin Approves 2 Big Solar Projects on Public Lands
Orbital Sciences Corp. Signs Commercial Launch Contract With Skybox Imaging
Broadcom Corporation Introduces New Global Navigation Satellite System for Wearable Fitness Technology
FDA to Review Merck's New HPV Vaccine
Wal-Mart's Earnings Slump Can't Stop the Dow's 100-Point Bounce
Why Raptor Pharmaceuticals Corp. Shares Clawed Higher
Why Shares of American Railcar Industries, Inc. Popped Today
BNSF Plans to Upgrade Tanker Fleet to Improve Safety
Will Facebook Ruin What's Great About WhatsApp?
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Read/Post Comments (0)
Recommend This Article (0)
Recommended 0 Times
Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment icon found on every comment.
Your Fool username will be displayed with your comment.
Please be respectful with your comments. Review our Fool's Rules.
Your comment may be delayed up to 15 minutes
DocumentId: 2846522, ~/Articles/ArticleHandler.aspx, 7/28/2014 9:19:39 AM
Use this area to report a comment that you believe
is in violation of the community guidelines. Our
team will review the entry and take any appropriate
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions